Literature DB >> 2940037

Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers.

G J Alexander, M Mondelli, N V Naumov, K T Nouriaria, D Vergani, D Lowe, A L Eddleston, R Williams.   

Abstract

Increased proportions of suppressor/cytotoxic T cells have been identified in the peripheral blood of chronic HBsAg carriers and to investigate a possible relationship to T cell cytotoxicity against autologous hepatocytes, suppressor cell activity, viral replication and the histological type of disease, 42 consecutive HBsAg carriers undergoing a liver biopsy have been investigated. The proportion of suppressor/cytotoxic lymphocytes directly correlated with T cell cytotoxicity to autologous hepatocytes and both were higher in those with HBeAg in serum than in those with anti-HBe or those on corticosteroid therapy. There was no relationship to underlying histological classification. In contrast, suppressor cell regulation of IgG producing cells was unrelated to the proportion of suppressor/cytotoxic lymphocytes in peripheral blood or HBeAg status, but impaired function was associated with chronic hepatitis, particularly chronic active hepatitis. These data suggest that the increased proportion of suppressor/cytotoxic lymphocytes in the peripheral blood of HBsAg carriers represents an increase in the cytotoxic and not the suppressor cell subset and that this is a consequence of active viral replication and not of the severity of hepatic inflammation. Defective suppressor cell function may be one factor in the development of chronic active hepatitis, but is not reflected by alterations in the T4:T8 ratio.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2940037      PMCID: PMC1577542     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Enhanced in vitro cell-mediated cytotoxicity in chronic hepatitis B virus infection: absence of specificity for virus-expressed antigen on target cell membranes.

Authors:  J L Dienstag; A K Bhan
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

2.  T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis b virus infection.

Authors:  A Alberti; G Realdi; F Bortolotti; A M Rigoli
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

3.  Regulatory T cell-subset imbalance in chronic active hepatitis.

Authors:  G Carella; L Chatenoud; F Degos; M A Bach
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

4.  Effect of corticosteroids on suppressor-cell activity in "autoimmune" and viral chronic active hepatitis.

Authors:  K T Nouri-Aria; J E Hegarty; G J Alexander; A L Eddleston; R Williams
Journal:  N Engl J Med       Date:  1982-11-18       Impact factor: 91.245

5.  Inducer and suppressor T-cells in hepatitis B virus-induced liver disease.

Authors:  H C Thomas; D Brown; G Routhier; G Janossy; P C Kung; G Goldstein; S Sherlock
Journal:  Hepatology       Date:  1982 Mar-Apr       Impact factor: 17.425

6.  Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.

Authors:  H F Eggink; H J Houthoff; S Huitema; C H Gips; S Poppema
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

7.  delta Antigen in hepatitis B: immunohistology of frozen and paraffin-embedded liver biopsies and relation to HBV infection.

Authors:  E Stöcklin; F Gudat; G Krey; U Dürmüller; M Gasser; M Schmid; G Stalder; L Bianchi
Journal:  Hepatology       Date:  1981 May-Jun       Impact factor: 17.425

8.  Functional properties of lymphocyte subpopulations in hepatitis B virus infection. II. Cytotoxic effector cell killing of targets that naturally express hepatitis B surface antigen and liver-specific lipoprotein.

Authors:  F V Chisari; M S Bieber; C A Josepho; C Xavier; D S Anderson
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

9.  Functional properties of lymphocyte subpopulations in hepatitis B virus infection. I. Suppressor cell control of T lymphocyte responsiveness.

Authors:  F V Chisari; K L Castle; C Xavier; D S Anderson
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

10.  In vitro study of IgG production and concanavalin A induced suppressor cell function in acute and chronic hepatitis B virus infection.

Authors:  K T Nouri-Aria; G J Alexander; B Portmann; D Vergani; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

View more
  5 in total

1.  Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues.

Authors:  B E Korba; P J Cote; F V Wells; B Baldwin; H Popper; R H Purcell; B C Tennant; J L Gerin
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

2.  Failure of exogenous interleukin 1 and interleukin 2 to correct decreased lymphocyte transformation in chronic hepatitis B virus carriers.

Authors:  C Anastassakos; G J Alexander; R A Wolstencroft; D C Dumonde; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

3.  Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load.

Authors:  Jing You; Lin Zhuang; Yi-Feng Zhang; Hong-Ying Chen; Hutcha Sriplung; Alan Geater; Virasakdi Chongsuvivatwong; Teerha Piratvisuth; Edward McNeil; Lan Yu; Bao-Zhang Tang; Jun-Hua Huang
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

4.  Flow cytometry CD4+/CD8+ ratio of liver-derived lymphocytes correlates with viral replication in chronic hepatitis B.

Authors:  B N Pham; J F Mosnier; F Walker; C Njapoum; F Bougy; C Degott; S Erlinger; J H Cohen; F Degos
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

5.  In vitro study of IgG production and concanavalin A induced suppressor cell function in acute and chronic hepatitis B virus infection.

Authors:  K T Nouri-Aria; G J Alexander; B Portmann; D Vergani; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.